Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Mediastinal Lymph Node Dissection in Gastroesophageal Junction Adenocarcinoma

  • Jin-Jo Kim (Division of Gastrointestinal Surgery, Department of Surgery, Incheon St. Mary's Hospital, The Catholic University of Korea)
  • Received : 2022.10.31
  • Accepted : 2022.12.13
  • Published : 2023.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Currently, the prevalence of gastroesophageal junction adenocarcinoma (GEJAC) is increasing in both Asian and Western countries, although the increasing rate in Asian countries is much slower than in Western countries. With these current trends, concerns regarding the surgical treatment method are also increasing among gastrointestinal surgeons. However, the surgical treatment for GEJAC has been a controversial issue for a long time due to the relative scarcity of this tumor and its characteristics from its borderline location. Recently, a large-scale prospective study of this tumor has been conducted in Japan, and the results are now available. The results of this study will be helpful for understanding this tumor. In this article, the pattern of lymph node metastasis of GEJAC is reviewed, and the extent and method of lymph node dissection for this tumor are discussed and proposed based on the review.

Keywords

References

  1. Kim JJ. Epidemiology of gastroesophageal junction adenocarcinoma in Korea. J Gastric Cancer 2018;18:328-338.  https://doi.org/10.5230/jgc.2018.18.e38
  2. Walther C, Zilling T, Perfekt R, Moller T. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997. Eur J Surg 2001;167:748-757.  https://doi.org/10.1080/11024150152707725
  3. Matsuno K, Ishihara R, Ohmori M, Iwagami H, Shichijyo S, Maekawa A, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol 2019;54:784-791.  https://doi.org/10.1007/s00535-019-01577-7
  4. Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-led nationwide survey on surgically treated gastric cancers in 2019. J Gastric Cancer 2021;21:221-235.  https://doi.org/10.5230/jgc.2021.21.e27
  5. Park SH, Kang MJ, Yun EH, Jung KW. Epidemiology of gastric cancer in Korea: trends in incidence and survival based on Korea Central Cancer Registry Data (1999-2019). J Gastric Cancer 2022;22:160-168.  https://doi.org/10.5230/jgc.2022.22.e21
  6. Eom SS, Choi W, Eom BW, Park SH, Kim SJ, Kim YI, et al. A comprehensive and comparative review of global gastric cancer treatment guidelines. J Gastric Cancer 2022;22:3-23.  https://doi.org/10.5230/jgc.2022.22.e10
  7. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction - classification, pathology and extent of resection. Dis Esophagus 1996;9:173-182.
  8. Wallner B. Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction. Surg Endosc 2009;23:2155-2158.  https://doi.org/10.1007/s00464-008-0238-9
  9. Misumi A, Murakami A, Harada K, Baba K, Akagi M. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir 1989;374:221-226.  https://doi.org/10.1007/BF01359557
  10. Ichihara S, Uedo N, Gotoda T. Considering the esophagogastric junction as a 'zone'. Dig Endosc 2017;29 Suppl 2:3-10.  https://doi.org/10.1111/den.12792
  11. Ekmektzoglou KA, Apostolopoulos P, Samelis G, Alexandrakis G. Gastroesophageal junction and gastroesophageal junction carcinoma: a short update. Acta Gastroenterol Belg 2016;79:471-479. 
  12. Hayashi T, Yoshikawa T. Optimal surgery for esophagogastric junctional cancer. Langenbecks Arch Surg 2022;407:1399-1407.  https://doi.org/10.1007/s00423-021-02375-7
  13. Mine S, Sano T, Hiki N, Yamada K, Nunobe S, Yamaguchi T. Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction. Br J Surg 2013;100:261-266. https://doi.org/10.1002/bjs.8967
  14. Matsuda T, Kurokawa Y, Yoshikawa T, Kishi K, Misawa K, Ohi M, et al. Clinicopathological characteristics and prognostic factors of patients with Siewert type II esophagogastric junction carcinoma: a retrospective multicenter study. World J Surg 2016;40:1672-1679.  https://doi.org/10.1007/s00268-016-3451-z
  15. Chen XD, He FQ, Chen M, Zhao FZ. Incidence of lymph node metastasis at each station in Siewert types II/III adenocarcinoma of the esophagogastric junction: a systematic review and meta-analysis. Surg Oncol 2020;35:62-70.  https://doi.org/10.1016/j.mpsur.2016.11.001
  16. Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study. Ann Surg 2021;274:120-127.  https://doi.org/10.1097/SLA.0000000000003499
  17. Aikou T, Shimazu H. Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 1989;19:290-295.  https://doi.org/10.1007/BF02471404
  18. Mine S, Kurokawa Y, Takeuchi H, Kishi K, Ito Y, Ohi M, et al. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors. Eur J Surg Oncol 2015;41:1348-1353.  https://doi.org/10.1016/j.ejso.2015.05.004
  19. Rudiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361.  https://doi.org/10.1097/00000658-200009000-00007
  20. Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 2003;90:850-853.  https://doi.org/10.1002/bjs.4106
  21. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112.  https://doi.org/10.1007/s10120-011-0041-5
  22. Haruta S, Shinohara H, Hosogi H, Ohkura Y, Kobayashi N, Mizuno A, et al. Proximal gastrectomy with exclusion of no. 3b lesser curvature lymph node dissection could be indicated for patients with advanced upper-third gastric cancer. Gastric Cancer 2017;20:528-535.  https://doi.org/10.1007/s10120-016-0624-2
  23. Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7:644-651.  https://doi.org/10.1016/S1470-2045(06)70766-5
  24. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus 2017;14:1-36.  https://doi.org/10.1007/s10388-016-0551-7
  25. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19.  https://doi.org/10.1007/s10120-016-0622-4
  26. Lee IS, Ahn JY, Yook JH, Kim BS. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol 2017;15:28. 
  27. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-1669.  https://doi.org/10.1056/NEJMoa022343
  28. Lee JS, Kim JJ, Park SM. A simple method of liver retraction for various types of laparoscopic upper gastrointestinal surgeries: the prolene hanging-up method. World J Surg 2015;39:2362-2366.  https://doi.org/10.1007/s00268-015-3065-x
  29. Kuroda S, Choda Y, Otsuka S, Ueyama S, Tanaka N, Muraoka A, et al. Multicenter retrospective study to evaluate the efficacy and safety of the double-flap technique as antireflux esophagogastrostomy after proximal gastrectomy (rD-FLAP Study). Ann Gastroenterol Surg 2018;3:96-103.  https://doi.org/10.1002/ags3.12216
  30. Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean Practice Guidelines for Gastric Cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 2023;23:3-106.   https://doi.org/10.5230/jgc.2023.23.e11